Glenn Wortmann is an Infectious Disease physician affiliated with MedStar Washington Hospital Center. OpenAlex indexes 149 publications with 5,873 citations (h-index 41); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
110 Irving St NW
Suite 2a38b
Washington, DC 200103017
Telephone
202-877-7164Registry record last updated 18 Jun 2013.
Clinical trials
- Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19
Sponsor: MedStar Health
- Sodium Stibogluconate Treatment of Leishmaniasis
Sponsor: U.S. Army Medical Research and Development Command
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Caris MPI, Inc.Program year20251 payment
- Janssen Pharmaceuticals, IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor29.3%Dovato47%Isentress27%Cabenuva27%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor19.2%Triumeq66%Emtricitabine-Tenofovir Disop34%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Shorr, MD
MedStar Washington Hospital Center
Kenneth Burman, MD
MedStar Washington Hospital Center
Toby Rogers, PhD
MedStar Washington Hospital Center
Rocco Armonda, MD
MedStar Washington Hospital Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”